Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65276 - 65300 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	MFN1	55669	upregulated	resveratrol results in increased expression of MFN1 mRNA	3q26.33	A23940
Resveratrol	Investigational	MFN2	9927	upregulated	resveratrol results in increased expression of MFN2 mRNA	1p36.22	A22289
Resveratrol	Investigational	MIA	8190	downregulated	resveratrol results in decreased expression of MIA mRNA	19q13.2	A23893
Resveratrol	Investigational	MICA	100507436	upregulated	resveratrol results in increased expression of MICA mRNA	6p21.33	A23972 A23968
Resveratrol	Investigational	MICB	4277	upregulated	resveratrol results in increased expression of MICB mRNA	6p21.33	A23972
Resveratrol	Investigational	MIR100	406892	upregulated	resveratrol results in increased expression of MIR100 mRNA	11q24.1	A23973
Resveratrol	Investigational	MIR103A1	406895	downregulated	resveratrol results in decreased expression of MIR103A1 mRNA	5q34	A23974
Resveratrol	Investigational	MIR103A2	406896	downregulated	resveratrol results in decreased expression of MIR103A2 mRNA	20p13	A23974
Resveratrol	Investigational	MIR122	406906	upregulated	resveratrol results in increased expression of MIR122 mRNA	18q21.31	A22517
Resveratrol	Investigational	MIR125A	406910	upregulated	resveratrol results in increased expression of MIR125A mRNA	19q13.41	A23975
Resveratrol	Investigational	MIR129-2	406918	downregulated	resveratrol results in decreased expression of MIR129-2 mRNA	11p11.2	A23975
Resveratrol	Investigational	MIR130A	406919	upregulated	resveratrol results in increased expression of MIR130A mRNA	11q12.1	A23975
Resveratrol	Investigational	MIR133B	442890	upregulated	resveratrol results in increased expression of MIR133B mRNA	6p12.2	A23975
Resveratrol	Investigational	MIR137	406928	upregulated	resveratrol results in increased expression of MIR137 mRNA	1p21.3	A23909
Resveratrol	Investigational	MIR143	406935	upregulated	resveratrol results in increased expression of MIR143 mRNA	5q32	A23976
Resveratrol	Investigational	MIR145	406937	upregulated	resveratrol results in increased expression of MIR145 mRNA	5q32	A23973 A23976
Resveratrol	Investigational	MIR146A	406938	downregulated	resveratrol results in decreased expression of MIR146A mRNA	5q33.3	A23974
Resveratrol	Investigational	MIR146B	574447	upregulated	resveratrol results in increased expression of MIR146B mRNA	10q24.32	A23974
Resveratrol	Investigational	MIR148A	406940	upregulated	resveratrol results in increased expression of MIR148A mRNA	7p15.2	A23975
Resveratrol	Investigational	MIR152	406943	downregulated	resveratrol results in decreased expression of MIR152 mRNA	17q21.32	A23975
Resveratrol	Investigational	MIR155	406947	downregulated	resveratrol results in decreased expression of MIR155 mRNA	21q21.3	A23977
Resveratrol	Investigational	MIR15A	406948	upregulated	resveratrol results in increased expression of MIR15A mRNA	13q14.2	A23975
Resveratrol	Investigational	MIR16-1	406950	downregulated	resveratrol results in decreased expression of MIR16-1 mRNA	13q14.2	A23974
Resveratrol	Investigational	MIR17	406952	downregulated	resveratrol results in decreased expression of MIR17 mRNA	13q31.3	A23974
Resveratrol	Investigational	MIR181A2	406954	downregulated	resveratrol results in decreased expression of MIR181A2 mRNA	9q33.3	A23974

Displaying entries 65276 - 65300 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability